trading halt, page-10

poie100 - my sentiments exactly. Interesting the company put out a trading halt - do we assume that "Intravitreal Injections" form a large part of the VEI business? Guess we will find out on Monday. Either way, in my opinion there is still a lot of fat in this stock. Its trading on a PER of 3 for FY12 earnings. The benefit of the EBIT share model is that doctor expense presumably will go down in line with any reduction in revenue based on this latest announcement. I think even with a cap raise at these levels, if the business can stabilise and the debt is renegotiated out of current liabilities then this is 70cent + stock.... If this announcement suggest earnings will be effected say by 10% and the stock gets belted back to mid to low 20s personally I will see it as a buying opportunity.